Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
30 Maio 2024 - 7:00AM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the
Company) today announced that it will attend the 2024 Jefferies
Global Healthcare Conference in New York from June 4-6, 2024.
Aurinia management will host one-on-one meetings with investors
and will participate in a presentation on Wednesday, June 5, from
8:00 to 8:25 AM Eastern Time. A live webcast of the session will be
available on the Investor section of Aurinia’s website, which can
be found here.
About Aurinia
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical
company focused on delivering therapies to people living with
autoimmune diseases with high unmet medical needs. In January 2021,
the Company introduced LUPKYNIS® (voclosporin), the first
FDA-approved oral therapy dedicated to the treatment of adult
patients with active lupus nephritis. The Company’s head office is
in Edmonton, Alberta, its U.S. commercial office is in Rockville,
Maryland. The Company focuses its development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240530835927/en/
Media and Investor Inquiries: Andrea Christopher
Corporate Communications and Investor Relations, Aurinia
achristopher@auriniapharma.com ir@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024